Latest news
BioMarin Lifts 2026 Outlook on Strong Voxzogo Sales, Wedbush Says - finance.yahoo.comfinance.yahoo.com · Fri, 07 Aug 2026 15:44:27 GMTBioMarin price target raised to $60 from $50 at H.C. Wainwright - TipRanksTipRanks · Fri, 07 Aug 2026 10:12:18 GMTBioMarin Pharmaceutical Q2 Non-GAAP Earnings Fall, Revenue Rises; Lifts 2026 Guidance - MoomooMoomoo · Thu, 06 Aug 2026 22:55:42 GMTBioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations - StockStoryStockStory · Thu, 06 Aug 2026 20:46:27 GMTBioMarin Pharmaceutical Inc. Provides Earnings Guidance for the Third and Fourth Quarter of 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 20:30:00 GMTBioMarin Pharmaceutical Inc. Updates Earnings Guidance for the Full Year 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 20:03:00 GMT